BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 26830086)

  • 1. Richter Syndrome in Chronic Lymphocytic Leukemia.
    Vitale C; Ferrajoli A
    Curr Hematol Malig Rep; 2016 Feb; 11(1):43-51. PubMed ID: 26830086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy.
    Jamroziak K; Tadmor T; Robak T; Polliack A
    Leuk Lymphoma; 2015 Jul; 56(7):1949-58. PubMed ID: 25356923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How we treat Richter syndrome.
    Parikh SA; Kay NE; Shanafelt TD
    Blood; 2014 Mar; 123(11):1647-57. PubMed ID: 24421328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biology and treatment of Richter syndrome.
    Rossi D; Spina V; Gaidano G
    Blood; 2018 Jun; 131(25):2761-2772. PubMed ID: 29692342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Richter Syndrome: Diagnostic and Therapeutic Management].
    Croizier C; Guièze R
    Bull Cancer; 2021 May; 108(5):521-527. PubMed ID: 33896586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Richter syndrome: molecular insights and clinical perspectives.
    Rossi D; Gaidano G
    Hematol Oncol; 2009 Mar; 27(1):1-10. PubMed ID: 19206112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Richter syndrome.
    Rossi D; Gaidano G
    Adv Exp Med Biol; 2013; 792():173-91. PubMed ID: 24014297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computed tomography textural analysis for the differentiation of chronic lymphocytic leukemia and diffuse large B cell lymphoma of Richter syndrome.
    Reinert CP; Federmann B; Hofmann J; Bösmüller H; Wirths S; Fritz J; Horger M
    Eur Radiol; 2019 Dec; 29(12):6911-6921. PubMed ID: 31236702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Richter syndrome: biology, incidence, and therapeutic strategies.
    Tsimberidou AM; Keating MJ
    Cancer; 2005 Jan; 103(2):216-28. PubMed ID: 15578683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunochemotherapy for Richter syndrome: current insights.
    Puła B; Salomon-Perzyński A; Prochorec-Sobieszek M; Jamroziak K
    Immunotargets Ther; 2019; 8():1-14. PubMed ID: 30788335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Richter syndrome in B-cell chronic lymphocytic leukemia.
    Nakamura N; Abe M
    Pathol Int; 2003 Apr; 53(4):195-203. PubMed ID: 12675762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
    Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
    Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Richter transformation in the brain from chronic lymphocytic leukemia.
    Ishida F; Nakazawa H; Takezawa Y; Matsuda K; Asano N; Sano K; Sakai H; Ito T
    J Clin Exp Hematop; 2013; 53(2):157-60. PubMed ID: 23995113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive markers and driving factors behind Richter syndrome development.
    Fangazio M; De Paoli L; Rossi D; Gaidano G
    Expert Rev Anticancer Ther; 2011 Mar; 11(3):433-42. PubMed ID: 21417856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome.
    Favini C; Talotta D; Almasri M; Andorno A; Rasi S; Adhinaveni R; Kogila S; Awikeh B; Schipani M; Boggione P; Mouhssine S; Ghanej J; Al Essa W; Mahmoud AM; Dondolin R; Alessa N; Margiotta Casaluci G; Boldorini R; Gattei V; Gaidano G; Moia R
    Br J Haematol; 2022 Sep; 198(6):1016-1022. PubMed ID: 35829664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Richter Syndrome.
    Condoluci A; Rossi D
    Curr Oncol Rep; 2021 Feb; 23(3):26. PubMed ID: 33580422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Richter's Syndrome.
    Condoluci A; Rossi D
    Curr Treat Options Oncol; 2017 Nov; 18(12):75. PubMed ID: 29159711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Richter syndrome epidemiology in a large population based chronic lymphocytic leukemia cohort from Norway.
    Lenartova A; Randen U; Johannesen TB; Tjønnfjord GE
    Cancer Epidemiol; 2019 Jun; 60():128-133. PubMed ID: 30986631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated Chronic Lymphocytic Leukemia and Richter Transformation in the Era of Novel Agents.
    Levy Yurkovski I; Tadmor T
    Acta Haematol; 2024; 147(1):73-83. PubMed ID: 37666234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Richter's transformation to diffuse large B-cell lymphoma: a retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLL Study Group.
    Tadmor T; Shvidel L; Bairey O; Goldschmidt N; Ruchlemer R; Fineman R; Rahimi-Levene N; Herishanu Y; Yuklea M; Arad A; Aviv A; Polliack A;
    Am J Hematol; 2014 Nov; 89(11):E218-22. PubMed ID: 25110869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.